Nestlé makes Atrium move
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Nestlé has signalled its intention to become a force in consumer healthcare by acquiring Canadian supplements specialist Atrium Innovations for US$2.3 billion (€1.95 billion) from a group of investors led by Permira Funds. Subject to regulatory approval, the transaction is expected to close in the first quarter of 2018.